research NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.





Vijayawada, Andhra Pradesh, India
Incomplete name
Brisbane, QLD, Australia
Incomplete name
Matteson, IL, United States
Madrid, Madrid, Spain
New Delhi, Delhi, India
Contagem, MG, Brazil